May 30th 2025
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Testicular Cancer Survivors at Risk of Late Effects of Chemotherapy
August 27th 2018“Since effective cisplatin-based chemotherapy was introduced in the 1970s, the overall age-adjusted five-year relative survival rate is 95 percent, and survivors remain at risk for decades for the late effects of cancer and its treatment,” the study authors wrote.